Johnson & Johnson to Participate in the Leerink Global Biopharma Conference
February 12 2024 - 4:10PM
Business Wire
Johnson & Johnson (NYSE: JNJ) will participate in the
Leerink Global Biopharma Conference on Tuesday, March 12th, at the
Fontainebleau Miami Beach, FL. Joe Wolk, Executive Vice President,
Chief Financial Officer will represent the Company in a session
scheduled at 1:00 p.m. (Eastern Time).
This live audio webcast will be available to investors and other
interested parties by accessing the Johnson & Johnson website
at www.investor.jnj.com.
The audio webcast replay will be available approximately 48-hrs
after the webcast.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240212450230/en/
Media contact: media-relations@its.jnj.com
Investor contact: investor-relations@its.jnj.com
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Jul 2023 to Jul 2024